Other reports of cerivastatin-induced rhabdomyolysis

被引：2

作者：

Gabay, M

Lodolce, A

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 2001年 / 161卷 / 21期

关键词：

D O I：

10.1001/archinte.161.21.2629

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2629 / 2629

页数：1

共 9 条

[1] Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil [J].

Alexandridis, G ;

Pappas, GA ;

Elisaf, MS .

AMERICAN JOURNAL OF MEDICINE, 2000, 109 (03) :261-262

[2] Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil [J].

Bermingham, RP ;

Whitsitt, TB ;

Smart, ML ;

Nowak, DP ;

Scalley, RD .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (05) :461-464

[3] Acute rhabdomyolysis associated with cerivastatin therapy [J].

Garcia-Valdecasas-Campelo, E ;

Gonzalez-Reimers, E ;

Lopez-Lirola, A ;

Rodriguez-Rodriguez, E ;

Santolaria-Fernandez, F .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (06) :893-893

[4]

Özdemir Ö, 2000, ANGIOLOGY, V51, P695

[5] Influenza vaccine - a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate [J].

Plotkin, E ;

Bernheim, J ;

Ben-Chetrit, S ;

Mor, A ;

Korzets, Z .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (05) :740-741

[6] Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy [J].

Pogson, GW ;

Kindred, LH ;

Carper, BG .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (07) :1146-+

[7] Cerivastatin-induced rhabdomyolysis [J].

Rodríguez, ML ;

Mora, C ;

Navarro, JF .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (07) :598-598

[8] Extending therapy options in treating lipid disorders - A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor [J].

Stein, EA .

DRUGS, 1998, 56 (Suppl 1) :25-31

[9] HMG-CoA reductase inhibitors and myotoxicity [J].

Ucar, M ;

Mjörndal, T ;

Dahlqvist, R .

DRUG SAFETY, 2000, 22 (06) :441-457

← 1 →